Design–Build–Scale: Synthetic biology Between Lab and Factory

Synthetic biology is making industrial biotechnology faster and more programmable. Europe’s breakthrough is still held back by scale-up realities, regulatory friction, market pull, and public trust. This session opens with a crisp overview of opportunities and challenges, followed by short, challenge-focused pitches and an interactive panel on what it will take to move from lab design to reliable industrial production and to unleash SynBio responsibly in Europe.